On the European Union level, the issue of how to strengthen the civil society involvement (CSI) in drug policy has increasingly attracted attention over the last few years, starting with the presentation of the “Green Paper on the role of Civil Society in Drugs Policy in the European Union” by the European Commission (2006) and the subsequent establishment of the “Civil Society Forum on Drugs” as a platform for regular dialogue on policy development and implementation between the Commission and representatives of European civil society. How the Civil Society Forum on Drugs is to be involved in EU drugs policy is further defined in the current EU Action Plan on Drugs 2017-2020 (Council of Europe 2017). However, the current action plan does n...
This paper describes the evolution of illicit drug supply reduction policy as part of the European U...
Taking stock: A decade of drug policy’ evaluates the impacts of drug policies implemented across the...
"This working paper presents the first results produced by a research group examining the impact of ...
BACKGROUND: Civil society organisations (CSOs) play a vital role in developing and implementing effe...
This study explores the civil society organisations that engage in drug policy advocacy in Europe. A...
1. Bulgaria 1.1. An example of strategic cooperation: Setting up a working group to discuss a plat...
Civil society organisations have long been involved in the response to drugs and drug use in Ireland...
Background In recent decades a range of advocacy organisations have emerged on the drugs policy lan...
This case study is about introducing patient and consumer representation in the regulatory process o...
This case study is about introducing patient and consumer representation in the regulatory process o...
The EU drugs action plan (2009–12) includes wide-ranging measures to strengthen European cooperation...
EU Commissioner Kyprianou has said that "We know that health policy can only be effective if it is i...
In the times of demise of nation states, emergence of diverse social risks and the Europeanization o...
Drug dependence is a multi-faceted problem, with links to major social scourges such as social exclu...
As the Strategy comes to an end in 2012 and a decision will need to be taken about its successor, th...
This paper describes the evolution of illicit drug supply reduction policy as part of the European U...
Taking stock: A decade of drug policy’ evaluates the impacts of drug policies implemented across the...
"This working paper presents the first results produced by a research group examining the impact of ...
BACKGROUND: Civil society organisations (CSOs) play a vital role in developing and implementing effe...
This study explores the civil society organisations that engage in drug policy advocacy in Europe. A...
1. Bulgaria 1.1. An example of strategic cooperation: Setting up a working group to discuss a plat...
Civil society organisations have long been involved in the response to drugs and drug use in Ireland...
Background In recent decades a range of advocacy organisations have emerged on the drugs policy lan...
This case study is about introducing patient and consumer representation in the regulatory process o...
This case study is about introducing patient and consumer representation in the regulatory process o...
The EU drugs action plan (2009–12) includes wide-ranging measures to strengthen European cooperation...
EU Commissioner Kyprianou has said that "We know that health policy can only be effective if it is i...
In the times of demise of nation states, emergence of diverse social risks and the Europeanization o...
Drug dependence is a multi-faceted problem, with links to major social scourges such as social exclu...
As the Strategy comes to an end in 2012 and a decision will need to be taken about its successor, th...
This paper describes the evolution of illicit drug supply reduction policy as part of the European U...
Taking stock: A decade of drug policy’ evaluates the impacts of drug policies implemented across the...
"This working paper presents the first results produced by a research group examining the impact of ...